ArticleAging2020

FX5 as a non-steroidal GR antagonist improved glucose homeostasis in type 2 diabetic mice via GR/HNF4α/miR-122-5p pathway.

Xin Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.